Effects of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and an eGFR below 30 ml/min/1.73 m2

29 August 2025 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Novel treatment approaches in heart failure and cardiomyopathies Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology